LINERIXIBAT MARKET: KEY INSIGHTS, GROWTH DRIVERS, AND FUTURE OUTLOOK

The Linerixibat Market is gaining traction in the pharmaceutical industry, primarily due to its promising potential to treat cholestatic pruritus in patients with primary biliary cholangitis (PBC). As an innovative IBAT inhibitor, Linerixibat has shown encouraging clinical trial results, positioning it as a crucial therapeutic option in the market.